Re: Executive Offer LetterExecutive Offer Letter • June 4th, 2021 • Graphite Bio, Inc. • Biological products, (no disgnostic substances) • California
Integral Medicines, Inc., a Delaware corporation (the “Company”), is pleased to offer you employment pursuant to the terms of this Executive Offer Letter (the “Agreement”).
ADVISOR AGREEMENTAdvisor Agreement • June 4th, 2021 • Graphite Bio, Inc. • Biological products, (no disgnostic substances) • California
THIS ADVISOR AGREEMENT (this “Agreement”) is made and entered into as of 3/24/20 (the “Effective Date”), by and between INTEGRAL MEDICINES, INC., a Delaware corporation (the “Company”), and MATTHEW PORTEUS (“Advisor”). The Company and Advisor may be referred to herein individually as “Party” or collectively as “Parties”.
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • June 4th, 2021 • Graphite Bio, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 11th day of March, 2021, by and among Graphite Bio, Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”, and each of the stockholders listed on Schedule B hereto, each of whom is referred to herein as a “Key Holder”.
